Boehringer Buys Abexxa To Boost Cancer Pipeline
Provided Initial Funding For Start-Up In 2016
The latest in a series of deals that Boehringer Ingelheim has inked in the oncology space will see the German family-run firm acquire US biotech Abexxa.
The latest in a series of deals that Boehringer Ingelheim has inked in the oncology space will see the German family-run firm acquire US biotech Abexxa.